Melissa Rewolinski - Jul 12, 2023 Form 3 Insider Report for Arbutus Biopharma Corp (ABUS)

Role
Director
Signature
/s/ David C. Hastings as attorney-in-fact for Melissa V. Rewolinski
Stock symbol
ABUS
Transactions as of
Jul 12, 2023
Transactions value $
$0
Form type
3
Date filed
7/13/2023, 04:11 PM
Previous filing
Sep 15, 2022
Next filing
May 24, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24: Power of Attorney